Fractyl Health, Inc. (GUTS)
NASDAQ: GUTS · IEX Real-Time Price · USD
3.940
-0.360 (-8.37%)
At close: Jul 19, 2024, 4:00 PM
3.980
+0.040 (1.02%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
Fractyl Health Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Fractyl Health stock has a target of 18, which predicts an increase of 356.85% from the current stock price of 3.94.
Analyst Consensus: Buy
* Price targets were last updated on Feb 27, 2024.
Analyst Ratings
The average analyst rating for Fractyl Health stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | May '24 | Jun '24 | Jul '24 |
---|---|---|---|
Strong Buy | 0 | 0 | 0 |
Buy | 2 | 2 | 2 |
Hold | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 |
Total | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Evercore ISI Group | Evercore ISI Group | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Feb 28, 2024 |
Morgan Stanley | Morgan Stanley | Buy Initiates $18 | Buy | Initiates | $18 | +356.85% | Feb 27, 2024 |
Financial Forecast
Revenue This Year
15.30K
from 120.00K
Decreased by -87.25%
Revenue Next Year
5.01M
from 15.30K
Increased by 32,632.03%
EPS This Year
-2.03
from -45.29
EPS Next Year
-2.61
from -2.03
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | 31,500 | 10.3M | 13.1M |
Avg | 15,300 | 5.0M | 12.7M |
Low | n/a | n/a | 12.2M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | -73.8% | 67,292.2% | 160.7% |
Avg | -87.3% | 32,632.0% | 153.3% |
Low | - | - | 143.3% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -1.90 | -2.56 | -3.14 |
Avg | -2.03 | -2.61 | -3.05 |
Low | -2.13 | -2.62 | -2.93 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.